Cleared Traditional

K113515 - HORIZON CARDIOLOGY ECG MANAGEMENT

K113515 is an FDA 510(k) clearance for HORIZON CARDIOLOGY ECG MANAGEMENT, manufactured by Mckesson Israel , Ltd.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 109-day FDA review.

K113515 · Mckesson Israel , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2012
Decision
109d
Days
Class 2
Risk

K113515 is an FDA 510(k) clearance for the HORIZON CARDIOLOGY ECG MANAGEMENT. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Mckesson Israel , Ltd. (Tel Aviv, IL). The FDA issued a Cleared decision on March 16, 2012 after a review of 109 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Mckesson Israel , Ltd. devices

FDA 510(k) Submission Details - K113515

510(k) Number K113515 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 2011
Decision Date March 16, 2012
Days to Decision 109 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 125d · This submission: 109d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 286
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K113515.
ST80I STRESS TEST SYSTEM
K121638 · Philips Health Care · Jul 2012
INTELLISPACE ECG
K120855 · Philips Health Care · Jun 2012
CARTO(R) EP NAVIGATION SYSTEM, VERSION 3.0 (WITH STANDARD LOCATION PAD)
K120550 · Biosense Webster, Inc. · May 2012
ENSITE VELOCITY SYSTEM V.3.0
K112688 · St Jude Medical · Nov 2011
MAC-LAB SYSTEM, CARDIOLAB SYSTEM, COMBOLAB SYSTEM, SPECIALSLAB SYSTEM
K111200 · Ge Healthcare · Oct 2011
CARTO 3 EP NAVIGATION SYSTEM, VERSION 2.2
K112007 · Biosense Webster, Inc. · Oct 2011